Attenuation of SARS-CoV-2 replication and associated inflammation by concomitant targeting of viral and host cap 2'-O-ribose methyltransferases.
The EMBO journal
View this publicationThe EMBO journal
View this publicationScientific reports
View this publicationMolecular therapy. Nucleic acids
View this publicationJournal of autoimmunity
View this publicationViruses
View this publicationInternational immunology
View this publicationInternational immunology
View this publicationScience (New York, N.Y.)
View this publicationMolecular and cellular biology
View this publicationNucleic acids research
View this publication